HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,453,211 | +20.5% | 324,707 | +13.3% | 1.28% | +27.0% |
| Q2 2023 | $10,333,694 | -6.3% | 286,490 | +0.3% | 1.00% | -9.2% |
| Q1 2023 | $11,028,310 | -32.6% | 285,722 | -0.3% | 1.11% | -33.8% |
| Q4 2022 | $16,367,967 | +30.6% | 286,523 | -9.2% | 1.67% | +19.5% |
| Q3 2022 | $12,529,000 | -5.0% | 315,584 | +5.3% | 1.40% | -1.5% |
| Q2 2022 | $13,192,000 | +58.2% | 299,825 | +33.3% | 1.42% | +66.0% |
| Q1 2022 | $8,338,000 | -26.5% | 224,849 | -19.5% | 0.86% | -24.7% |
| Q4 2021 | $11,338,000 | -4.0% | 279,423 | -3.8% | 1.14% | -4.6% |
| Q3 2021 | $11,813,000 | -6.1% | 290,394 | +4.9% | 1.19% | -2.5% |
| Q2 2021 | $12,575,000 | +12.2% | 276,912 | +3.0% | 1.22% | +4.7% |
| Q1 2021 | $11,211,000 | +8.7% | 268,917 | +11.4% | 1.17% | -10.5% |
| Q4 2020 | $10,309,000 | +32.8% | 241,362 | -17.5% | 1.30% | +32.9% |
| Q3 2020 | $7,761,000 | -1.0% | 292,570 | +0.9% | 0.98% | -3.9% |
| Q2 2020 | $7,840,000 | +53.2% | 290,087 | +2.1% | 1.02% | +20.8% |
| Q1 2020 | $5,118,000 | – | 284,143 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |